MX2021002170A - Composiciones fotoprotectoras que contienen compuestos derivados de malassezia y/o analogos quimicos de los mismos. - Google Patents

Composiciones fotoprotectoras que contienen compuestos derivados de malassezia y/o analogos quimicos de los mismos.

Info

Publication number
MX2021002170A
MX2021002170A MX2021002170A MX2021002170A MX2021002170A MX 2021002170 A MX2021002170 A MX 2021002170A MX 2021002170 A MX2021002170 A MX 2021002170A MX 2021002170 A MX2021002170 A MX 2021002170A MX 2021002170 A MX2021002170 A MX 2021002170A
Authority
MX
Mexico
Prior art keywords
compounds
malassezia
hyperpigmentation
compositions
chemical analogs
Prior art date
Application number
MX2021002170A
Other languages
English (en)
Inventor
Michael Einziger
Ann Marie Simpson
Original Assignee
Michael EINZIGER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael EINZIGER filed Critical Michael EINZIGER
Publication of MX2021002170A publication Critical patent/MX2021002170A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se refiere a compuestos, composiciones y métodos para modular la pigmentación de la piel y tratar o prevenir el daño cutáneo inducido por los rayos UV, el eritema, el envejecimiento de la piel, las quemaduras solares y la hiperpigmentación en un sujeto; los compuestos, composiciones y métodos de la presente invención generalmente implican compuestos derivados de Malassezia, que incluyen malassezina e indirubina, y/o análogos químicos de las mismas; otras aplicaciones de los compuestos y composiciones descritas en este documento incluyen, pero no se limitan a, mejorar la hiperpigmentación causada por un trastorno de hiperpigmentación, inducir la apoptosis de los melanocitos y modular la actividad del receptor de arilhidrocarburos (AhR), melanogénesis, producción de melanina, biogénesis de melanosomas, transferencia de melanosomas, melanocitos actividad y concentración de melanina.
MX2021002170A 2018-08-24 2019-08-23 Composiciones fotoprotectoras que contienen compuestos derivados de malassezia y/o analogos quimicos de los mismos. MX2021002170A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862722412P 2018-08-24 2018-08-24
US201862742657P 2018-10-08 2018-10-08
PCT/US2019/047831 WO2020041663A1 (en) 2018-08-24 2019-08-23 Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof

Publications (1)

Publication Number Publication Date
MX2021002170A true MX2021002170A (es) 2021-04-28

Family

ID=67902591

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021002170A MX2021002170A (es) 2018-08-24 2019-08-23 Composiciones fotoprotectoras que contienen compuestos derivados de malassezia y/o analogos quimicos de los mismos.

Country Status (14)

Country Link
US (2) US11202748B2 (es)
EP (1) EP3841103A1 (es)
JP (1) JP2021535123A (es)
KR (1) KR20210071963A (es)
CN (1) CN113795494A (es)
AU (1) AU2019325408A1 (es)
BR (1) BR112021003490A2 (es)
CA (1) CA3110495A1 (es)
IL (1) IL281078A (es)
MX (1) MX2021002170A (es)
PH (1) PH12021550315A1 (es)
SG (1) SG11202101835UA (es)
TW (1) TW202023522A (es)
WO (1) WO2020041663A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020020881A2 (pt) * 2018-04-12 2021-04-20 Michael EINZIGER composições fotoprotetoras contendo compostos derivados de malassezia e/ou análogos químicos dos mesmos
AU2019325408A1 (en) * 2018-08-24 2021-03-11 Michael EINZIGER Photoprotective compositions containing
CN117298119B (zh) * 2023-11-28 2024-01-23 云南中医药大学 色胺酮衍生物在制备抗耐药白念珠菌药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9969686B2 (en) 2014-08-05 2018-05-15 Wisconsin Alumni Research Foundation Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed thereby, and pharmaceutical compositions containing them
KR20160128764A (ko) * 2015-04-29 2016-11-08 주식회사 엘지생활건강 피부 개선용 조성물
EA201892030A1 (ru) * 2016-03-10 2019-02-28 Майкл Айнцигер Малассезин и его аналоги в качестве осветляющих кожу агентов
BR112020020881A2 (pt) 2018-04-12 2021-04-20 Michael EINZIGER composições fotoprotetoras contendo compostos derivados de malassezia e/ou análogos químicos dos mesmos
AU2019267554A1 (en) 2018-05-07 2020-12-03 Michael EINZIGER Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
AU2019325408A1 (en) * 2018-08-24 2021-03-11 Michael EINZIGER Photoprotective compositions containing

Also Published As

Publication number Publication date
AU2019325408A1 (en) 2021-03-11
US11202748B2 (en) 2021-12-21
TW202023522A (zh) 2020-07-01
WO2020041663A1 (en) 2020-02-27
CA3110495A1 (en) 2020-02-27
JP2021535123A (ja) 2021-12-16
US20220110848A1 (en) 2022-04-14
BR112021003490A2 (pt) 2021-05-18
IL281078A (en) 2021-04-29
EP3841103A1 (en) 2021-06-30
PH12021550315A1 (en) 2021-10-25
SG11202101835UA (en) 2021-03-30
KR20210071963A (ko) 2021-06-16
CN113795494A (zh) 2021-12-14
WO2020041663A8 (en) 2021-11-25
US20200060952A1 (en) 2020-02-27

Similar Documents

Publication Publication Date Title
PH12021550315A1 (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
PH12020551677A1 (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
PH12018501926A1 (en) Malassezin and analogs thereof as skin brightening agents
PH12015502246A1 (en) Benzimidazolone derivatives as bromodomain inhibitors
PH12020552132A1 (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
PH12020551845A1 (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
MX2022003140A (es) Composicion para aclarar la piel.
EA201490613A1 (ru) Соединения с замедляющим старение действием
EA201890886A1 (ru) Композиция для отбеливания кожи
MX2015008783A (es) Composicion cosmetica dermatologica que comprende una merocianina y una fase aceitosa que comprende al menos un compuesto amido especifico.
PH12019502721A1 (en) Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin
WO2014090526A3 (de) Wirkstoffkombination zur hautaufhellung i
PH12021550746A1 (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
MX358394B (es) Composicion cosmetica o dermatologica que comprende una merocianina, un agente de filtro ultravioleta b (uvb) organico y un agente de filtro ultravioleta a (uva) organico adicional.
WO2014090525A3 (de) Reduzierung des ammoniakgeruchs in mitteln zum oxidativen färben und/oder aufhellen von keratinischen fasern
MX2015009054A (es) Composicion cosmetica o dermatologica que comprende una merocianina, una fase aceitosa y un monoalcanol c1-c4.
EA201791493A1 (ru) Композиция для отбеливания кожи, содержащая ниацинамид и иломастат
WO2014111569A3 (en) Anhydrous cosmetic or dermatological composition comprising a merocyanine and an oily phase
MD20110040A1 (ro) Inhibitori ai leucemiei mieloide umane în baza 2-[2-(piridin-2-ilmetiliden)hidrazino]-1,3-benzotiazolului şi 2-[2-(1-piridin-2-iletiliden)hidrazino]-1,3-benzotiazol dihidratului
MX2020010498A (es) Composiciones para el cuidado de la piel y sus aplicaciones.
MX2024009744A (es) Analogos de tofa, preparaciones para la reduccion del sebo con un contenido de tales analogos y el uso cosmetico y/o terapeutico de tales analogos como principio eficaz para la reduccion o prevencion del sebo.
FR3060992B1 (fr) Composes depigmentants
EA201492153A1 (ru) Смесь для ингибирования биосинтеза меланина
Massey Prednisone/voriconazole
MX2017011229A (es) Difluoro compuestos de gema como agentes de despigmentacion o de aclaramiento.